Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, completed the acquisition of a 54% interest in CliniQuantum Ltd., an Israeli company specializing in quantum simulation for clinical trial data analysis. The acquisition includes issuance of NeuroThera shares to CliniQuantum shareholders and potential earn-out payments contingent…
Plus Therapeutics announced that CNSide Diagnostics, its wholly owned subsidiary, has achieved College of American Pathologists (CAP) accreditation for its Houston-based clinical laboratory. This accreditation validates the laboratory's high standards and quality controls, strengthening its position to expand the commercial use of the CNSide® CSF A…
Rezolute, Inc., a late-stage biotech company focused on treatments for refractory hypoglycemia due to hyperinsulinism, announced four presentations at the 2026 Endocrine Society Annual Meeting. These include data from the Phase 3 sunRIZE study of their drug ersodetug, which previously failed to meet primary endpoints but showed consistent glycemic …
Biogen Inc. announced that the FDA has granted Breakthrough Therapy Designation to its investigational antisense oligonucleotide, salanersen, for treating spinal muscular atrophy (SMA). Supported by positive Phase 1b data showing motor function improvements and slowing neurodegeneration in children with SMA, salanersen offers potential high efficac…
Jade Biosciences shares plunged in pre-market trading after the company priced a sizeable secondary offering well below the prior session close. The planned sale of 10 million shares at $15.00, with a 30-day option for underwriters to buy an additional 1.5 million shares, created dilution concerns and anchored near-term price expectations, while a …
At least seven students from a polytechnic in Zamfara State were seized by gunmen in the early hours of June 3, police said, after attackers stormed rented student housing on the outskirts of Kaura Namoda town. Security forces were dispatched but the assailants had fled before arrival. Authorities say search-and-rescue efforts have been intensified…
Goldman Sachs upgraded Wartsila from Sell to Neutral and raised its 12-month price target to €34 from €26.30 after boosting adjusted EBIT estimates for 2026-2029 by 12-18%. The change follows the company’s announcements of substantial capacity investments that together increase technical production capacity by 65% above 2025 levels and a management…
ITV's chief executive, Carolyn McCall, said the broadcaster remains in active discussions with Comcast's Sky about a potential sale of its media and entertainment arm. McCall declined to provide further specifics at the Enders TMT Leaders Live conference, citing ITV's obligations as a publicly traded company. The proposed transaction, first announc…
Grifols is trading cheaply (market cap $6.42B, P/E ~10.6, P/B ~0.81) while the underlying plasma-derived therapies market is growing strongly. Near-term headline risk out of Canada has hit the stock, but resolution or containment of that regulatory episode, combined with improved plasma self-sufficiency trends and continued demand for immunoglobuli…
Microchip Technology's Armenian office has received a U.S. Department of Commerce export license authorizing them to develop advanced FPGA technologies within Armenia. This approval strengthens Armenia's role in the global semiconductor supply chain and supports Microchip’s commitment to innovation through expanded global engineering collaboration.
NBT Bancorp (NBTB) trades at a modest P/E of ~12.7 and a P/B near 1.22, pays a 3.2% yield, and has scale ($16.11B assets) following the Evans Bancorp merger. This trade targets $52 with a $40 stop, keyed to stable fundamentals, improving footprint in Upstate New York, and attractive cash flow metrics.
Less than two weeks before the 2026 World Cup begins in North America, public excitement in Argentina is noticeably restrained compared with the frenetic atmosphere that followed the team's 2022 triumph in Qatar. While promotional campaigns featuring Lionel Messi and the national squad are widespread, many fans describe a quieter optimism and lower…
SAP stock jumped in pre-market trading after the vendor used its Sapphire 2026 conference to outline a sweeping AI strategy called the "Autonomous Enterprise," backed by an immediate rollout of assistant and agent capabilities, a €100 million partner AI fund, an intended acquisition of Dremio, and a substantial commitment to Prior Labs. The moves, …
Solidion Technology Inc. (NASDAQ:STI) saw its shares climb 200% on Thursday after revealing a patented Generation Extreme-Climate Battery (Gen-ECB) platform designed to function across a wide temperature range for space applications. The company highlighted graphene-based thermal and radiation protections, demonstrated cycle life at cold temperatur…
Bank of America upgraded UnitedHealth Group to Buy from Neutral and lifted its price target to $450 from $420, citing improving medical-cost trends and near-term utilization data that set up a favorable second-quarter earnings backdrop. Analyst Kevin Fischbeck says BofA's revised estimates place the new target at 21.4x 2027 figures and that the fir…
Microchip Technology is showing early signs of margin stabilization while its data center business is scaling quickly. With the Data Center Solutions unit posting $302.7M in 2025 and management projecting roughly $500M in 2026 (a 65% increase), the stock can re-rate if margins and free cash flow continue improving. This is a tactical swing trade: e…
BofA Securities upgraded Epiroc AB to Buy from Underperform and FLSmidth to Buy from Neutral, citing a wave of copper project final investment decisions (FIDs) over the next four years. The bank sees material upside to upstream original equipment orders in 2026-2027 and raised price targets for both Epiroc and FLSmidth, while reiterating its Buy on…
Global-e Online Ltd., a leading global direct-to-consumer e-commerce platform, announced that its Board of Directors has authorized a new share repurchase program of up to $500 million. This follows completion of about 80% of their previous $200 million repurchase plan. The program aims to return capital to shareholders while supporting strategic i…
The Catalyst/Millburn Hedge Strategy Fund (MBXIX) has exceeded $10 billion in assets under management, signaling increasing investor demand for alternative investment strategies that offer diversification and resilience through both bull and bear markets. The fund employs a systematic long/short managed futures approach combined with strategic equi…
Plug Power Inc. announced its annual shareholder meeting webcast will take place on June 11, 2026, featuring a presentation by CEO Jose Luis Crespo on the company’s corporate overview and operations in the hydrogen economy. The webcast is accessible to shareholders and the public, highlighting Plug Power's progress in hydrogen solutions, electrolyz…
Option Care Health, the largest independent provider of home and alternate site infusion services in the US, announced the appointment of Robert Okunski as Vice President of Investor Relations. Okunski brings over 20 years of expertise in investor relations across healthcare and technology sectors and will lead the company's strategy to improve com…
AEON Biopharma announced presentation of new analytical and functional data at the 68th Annual Scientific Meeting of the American Headache Society demonstrating structural and functional comparability of its biosimilar candidate ABP-450 to BOTOX®. The data reinforce biosimilarity using multiple analytical methods, supporting AEON's pursuit of full-…
Axsome Therapeutics presented new clinical data on SYMBRAVO®, its investigational migraine treatment, at the American Headache Society 68th Annual Scientific Meeting. The data highlights SYMBRAVO's efficacy and safety in acute migraine treatment from multiple studies, supporting its potential market impact in CNS disorder therapeutics. Axsome conti…
U.S. Energy Corp. officially changes its name and ticker symbol to Big Sky Industrial Inc. to reflect its strategic focus on helium production, carbon management through its Big Sky Carbon Hub project in Montana, and low-decline oil operations. The company has reached final investment decision on processing facilities, secured contracted cash flows…
BeyondSpring Inc., a clinical-stage biopharmaceutical company, announced a strategic leadership transition effective July 1, 2026, to focus on executing its confirmatory DUBLIN-4 Phase 3 trial for Plinabulin in non-squamous EGFR wild-type NSCLC patients. The company appoints Min Qiu as CEO with a mandate to complete DUBLIN-4, extend Plinabulin's sc…
